Domov › Kolorektálny karcinóm › Ohio › Columbus
Klinické štúdie Kolorektálny karcinóm v meste Columbus, OH
24 štúdií pre Kolorektálny karcinóm hľadá účastníkov v zariadeniach v meste Columbus a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Prebieha náborFáza 2
- Ohio State University Comprehensive Cancer Center, Columbus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- a 8 ďalších
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Prebieha náborFáza 1
- ALX Center 10, Columbus
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Prebieha náborObservačná štúdia
- The Ohio State University Comprehensive Cancer Center, Columbus
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Prebieha náborFáza 3
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
Prebieha náborFáza 1
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Prebieha náborFáza 2/3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Prebieha náborFáza 2
- Research Site, Columbus
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Prebieha náborFáza 3
- Ohio State University-Arthur G James Comprehensive Cancer Center, Columbus
- Ohio Health, Columbus
- Zangmeister Center, Columbus
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Prebieha náborFáza 1
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Prebieha náborFáza 1
- The Ohio State University (OSU) Wexner Medical Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Prebieha náborFáza 1/2
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Prebieha náborFáza 2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Prebieha náborFáza 4
- Zangmeister Cancer Center, Columbus
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Prebieha náborFáza 1/2
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Prebieha náborFáza 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Prebieha náborFáza 1
- Ohio State University, Columbus
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Prebieha náborFáza 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Prebieha náborObservačná štúdia
- Memorial Hospital, Marysville · 27 míľ odtiaľ
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Prebieha náborObservačná štúdia
- The Mark H Zangmeister Center, Columbus
The Ohio State University (OSU) SCREEN Community Program
Prebieha náborVítaní zdravých dobrovoľníkov
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Prebieha náborFáza 1/2
- The Ohio State University, Columbus
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Prebieha náborObservačná štúdia
- Ohio State University, Columbus
- OhioHealth Research Institute, Columbus
Štúdie Kolorektálny karcinóm v iných mestách
- Houston, TX102 štúdií
- New York City, NY78 štúdií
- Nashville, TN69 štúdií
- Boston, MA63 štúdií
- Los Angeles, CA59 štúdií
- Arlington, VA52 štúdií
- St. Louis, MO50 štúdií
- San Antonio, TX46 štúdií
- Philadelphia, PA44 štúdií
- Grand Rapids, MI40 štúdií
- Baldwin Park, CA37 štúdií
- Chicago, IL34 štúdií
Iné štúdie v Columbus
- Nemalobunkový karcinóm pľúc57 štúdií
- Rakovina prsníka40 štúdií
- Rakovina vaječníkov39 štúdií
- Rakovina (všetky typy)38 štúdií
- Rakovina pľúc37 štúdií
- Akútna myeloidná leukémia35 štúdií
- Chronická lymfocytová leukémia28 štúdií
- Metastatická rakovina27 štúdií
- Rakovina endometria25 štúdií
- Rakovina prostaty24 štúdií
- Mnohonásobný myelóm24 štúdií
- Melanóm21 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.